PROTEUS Substudy Reports 63% of Prostate Cancer Patients Avoid Recurrence With Combination Therapy

Estimated read time 1 min read

(NaturalNews) A substudy of the PROTEUS trial found that 63% of men who received the hormone therapy apalutamide plus androgen-deprivation therapy before and after …

You May Also Like

More From Author